BioLine Rx Ltd (BLRX)
0.6569
-0.03
(-4.12%)
USD |
NASDAQ |
May 10, 16:00
0.6569
0.00 (0.00%)
After-Hours: 20:00
BioLine Rx Free Cash Flow (Quarterly): 4.973M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.973M |
| September 30, 2023 | -9.928M |
| June 30, 2023 | -9.805M |
| March 31, 2023 | -8.145M |
| December 31, 2022 | -5.911M |
| September 30, 2022 | -8.708M |
| June 30, 2022 | -6.333M |
| March 31, 2022 | -5.604M |
| December 31, 2021 | -5.565M |
| September 30, 2021 | -5.01M |
| June 30, 2021 | -6.847M |
| March 31, 2021 | -6.248M |
| December 31, 2020 | -5.431M |
| September 30, 2020 | -5.471M |
| June 30, 2020 | -5.566M |
| March 31, 2020 | -6.738M |
| December 31, 2019 | -5.449M |
| September 30, 2019 | -6.17M |
| June 30, 2019 | -6.467M |
| March 31, 2019 | -4.653M |
| December 31, 2018 | -15.24M |
| September 30, 2018 | -6.014M |
| June 30, 2018 | -6.263M |
| March 31, 2018 | -6.89M |
| December 31, 2017 | -6.732M |
| Date | Value |
|---|---|
| September 30, 2017 | -6.236M |
| June 30, 2017 | -4.261M |
| March 31, 2017 | -7.556M |
| December 31, 2016 | -3.952M |
| September 30, 2016 | -2.982M |
| June 30, 2016 | -3.302M |
| March 31, 2016 | -4.332M |
| December 31, 2015 | -3.419M |
| September 30, 2015 | -4.73M |
| June 30, 2015 | -5.119M |
| March 31, 2015 | -3.619M |
| December 31, 2014 | -4.807M |
| September 30, 2014 | -3.312M |
| June 30, 2014 | -4.386M |
| March 31, 2014 | -3.438M |
| December 31, 2013 | -3.89M |
| September 30, 2013 | -4.307M |
| June 30, 2013 | -6.172M |
| March 31, 2013 | -5.273M |
| December 31, 2012 | -6.802M |
| September 30, 2012 | -4.066M |
| June 30, 2012 | -5.838M |
| March 31, 2012 | -3.585M |
| December 31, 2011 | -4.099M |
| September 30, 2011 | -1.007M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-9.928M
Minimum
Sep 2023
4.973M
Maximum
Dec 2023
-6.022M
Average
-6.17M
Median
Sep 2019
Free Cash Flow (Quarterly) Benchmarks
| Compugen Ltd | -- |
| Pluri Inc | -3.77M |
| XTL Biopharmaceuticals Ltd | -- |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | -6.249M |